Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Rahmer Insider Profile
4 Followers
Peter Rahmer, Chief Corporate Development Officer at Relay Therapeutics, holds 402.43K shares in Relay Therapeutics (Ticker: RLAY).
Peter Rahmer Relay Therapeutics (RLAY)Chief Corporate Development Officer
Relay Therapeutics (RLAY)
Chief Corporate Development Officer
Ranked #1,355 out of 100,516 Corporate Insiders
Profitable Transactions
18 out of 19 Profitable Transactions
Average Return
+34.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Corporate Development Officer
Roles that Peter Rahmer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 29, 2023 - Dec 29, 2024
Return:+60.30%
The most profitable trade made by Peter Rahmer
Peter Rahmer's Trading History
List of latest transactions for each holding click on a transaction to see Peter Rahmer's performance on stock
You May Also Like
Peter Rahmer insider profile FAQ
What is the percentage of profitable transactions made by Peter Rahmer?
The percentage of profitable transactions made by Peter Rahmer is 95%.
What is the average return per transaction made by Peter Rahmer?
The average return per transaction made by Peter Rahmer is 34.10%.
What stocks does Peter Rahmer hold?
Peter Rahmer holds: RLAY stocks.
What was Peter Rahmer’s latest transaction?
Peter Rahmer latest transaction was an Uninformative Buy of ―.
What was Peter Rahmer's most profitable transaction?
Peter Rahmer’s most profitable transaction was an Informative Sell of RLAY stock on December 29, 2023. The return on the trade was 60.30%.
What is Peter Rahmer's role in Relay Therapeutics?
Peter Rahmer's role in Relay Therapeutics is Chief Corporate Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.